Literature DB >> 16415638

Building on the specialist's antihypertensive treatment recommendation: it's just the beginning.

Elijah Saunders1.   

Abstract

Patients with established cardiovascular disease are a top priority for preventive medicine. Evidence from clinical trials supports the merits of aggressive risk reduction therapies in survivors of an acute event. Improving their cardiovascular risk factor profile prolongs survival, reduces the incidence of recurrent atherosclerotic events, and improves quality of life. Blood pressure (BP) control is an essential component of cardiovascular disease secondary prevention programs; however, many patients are not receiving adequate antihypertensive therapy to meet their BP goal. By building on the specialist's discharge antihypertensive prescription, primary care physicians are ideally positioned to assume responsibility for ensuring BP goals are achieved and maintained over the long term in patients who have survived an acute event. Current hypertension management guidelines define appropriate BP goals and incorporate clear advice on how these goals can be met. BP should be lowered slowly and carefully through lifestyle modifications and pharmacologic therapy. Antihypertensive treatment should be given according to guidelines for primary prevention, although specific antihypertensive classes are indicated for initial use in post-myocardial infarction and post-stroke patients. In many cases, BP goal attainment will require the use of combination therapy with two or more drugs from different classes. With the availability of effective and safe antihypertensive drug therapies, including fixed-dose combinations, a BP goal of <140/90 mm Hg should be achievable in most patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415638      PMCID: PMC8109729          DOI: 10.1111/j.1524-6175.2005.05296.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  66 in total

1.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Authors:  S C Smith; S N Blair; R O Bonow; L M Brass; M D Cerqueira; K Dracup; V Fuster; A Gotto; S M Grundy; N H Miller; A Jacobs; D Jones; R M Krauss; L Mosca; I Ockene; R C Pasternak; T Pearson; M A Pfeffer; R D Starke; K A Taubert
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

2.  Chronic management of blood pressure after stroke.

Authors:  Laura Pedelty; Philip B Gorelick
Journal:  Hypertension       Date:  2004-05-10       Impact factor: 10.190

3.  Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.

Authors:  Douglas L Mann; Anita Deswal
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

4.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

5.  EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Authors: 
Journal:  Eur Heart J       Date:  1997-10       Impact factor: 29.983

6.  Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group.

Authors:  A Rodgers; S MacMahon; G Gamble; J Slattery; P Sandercock; C Warlow
Journal:  BMJ       Date:  1996-07-20

7.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.

Authors:  L G Ogden; J He; E Lydick; P K Whelton
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

8.  Five-year prognosis after acute myocardial infarction in relation to a history of hypertension.

Authors:  J Herlitz; A Bång; B W Karlson
Journal:  Am J Hypertens       Date:  1996-01       Impact factor: 2.689

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

Authors: 
Journal:  JAMA       Date:  1982-03-26       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.